During EMT and cancer progression, when hemidesmosomes are lost, the cytoplasmic domain of ITGβ4 is phosphorylated, which releases the integrin α6β4 from the hemidesmosomes and freely interacts with different growth factors receptors such as the epidermal growth factor receptor (EGFR). This evidence concerns the gene ITGB4 and cancer.